Uncategorised
A drug that was recently approved by the US Food and Drug Administration (FDA) has been shown to significantly reduce the risk of stroke and heart attacks in diabetes patients. Sotagliflozin has been approved to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors. The medication is a sodium-glucose cotransporter (SGLT) inhibitor [...]
A newly developed blood test may enable better diagnosis, earlier interventions and more targeted treatments for Alzheimer's disease. Researchers are exploring the ability of a new plasma p-tau217 blood test to detect Alzheimer’s Disease. The team say the test could potentially replace the current diagnostic method, a lumbar puncture/spinal tap (which is invasive and poses [...]
A new study has revealed for the first time that a gene “silencer” that resides in junk DNA is directly sparing people from a devastating and fatal progressive neurological disease – called autosomal dominant leukodystrophy (ADLD). The discovery explains why not all people with the genetic mutation develop the disease and has significant implications for [...]
Neurogeneticists have discovered a novel genetic mutation and associated buildup of toxic proteins in the brain - a type of buildup distinct from amyloid or tau, proteins that have long been the focus of Alzheimer’s research. Unexpectedly, the investigators found that 45 of 80 autopsy brains of Alzheimer’s patients showed the accumulation of toxic proteins [...]
In the following article, written by Ellice Wood, Highly Specialist Speech and Language Therapist at St Andrew’s Healthcare, Ellice discusses how building understanding, empathy and emotional resilience can break down barriers in communication, demonstrating the profound impact of Speech and Language Therapy on mental health and social integration. In mental healthcare, the importance of Speech [...]
Researchers in the US have discovered a new pathway to forming long-term memories in the brain - a finding that opens up possibilities for understanding memory-related conditions. Our brain works diligently to record our experiences into memories, creating representations of our daily events that stay with us for short time periods. Current scientific theories of [...]
Researchers have discovered that by inhibiting the brain enzyme S-acyltransferase (zDHHC) through a nasal-spray drug, they can counteract the cognitive decline and brain damage typical of Alzheimer's disease. Researchers have observed that the post-mortem brains of Alzheimer's disease patients contained an excess of S-acyltransferase, which could be a promising therapeutic target of new drugs. They [...]
A team of researchers has developed a minimally invasive neural interface to enable diagnosing, managing and treating neurological disorders with minimal surgical risks. Traditional approaches for interfacing with the nervous system often require creating a hole in the skull to interface with the brain. In a revolutionary study, researchers have now developed an innovative method [...]
Three leading neuro rehab organisations have been shortlisted for an NR Times Award. The Rehab Outcome of the Year award recognises cases in which patients have secured life-changing progress through the work of either an individual practitioner or business, or that of an MDT, enabling them to look to an infinitely more positive future. The [...]
All too often, navigating company growth through grant funding seems like a complex maze, with no clear path forward and little guidance to follow. Kompass (formerly Goal Manager) has successfully secured grant funding in the rehabilitation industry and believes that this process should be more accessible to others. After all, if more companies that enhance [...]
